PARP inhibitors have proven to be particularly valuable in improving progression-free survival for patients with certain types of ovarian cancer. But unfortunately, these gains come at a high financial cost … Continued
February 16, 2021 President Joseph R. Biden, Jr.The White House1600 Pennsylvania Avenue, NWWashington, DC 20500 Dear Mr. President: On behalf of a broad spectrum of organizations, cancer centers, and other … Continued
We have great hope for the year ahead, and much of that is buoyed by what we accomplished, with your help, in 2020. A quick look back at the numbers… … Continued
If you’ve ever wanted to join us for Spring Advocacy Day, but couldn’t make it to Capitol Hill, now is your chance! Every spring, we bring together survivors, caregivers and … Continued
Registration closes on December 17, 2021. Together, we made great strides in 2020 on Capitol Hill, and we are excited to announce that we now have more OCRA Advocate Leaders … Continued
We’re probably all ready to say goodbye to 2020, if we have to be honest with ourselves. And yet, we can’t look back and say that the year was entirely bad. With your … Continued
Urge your U.S. Senators to restore full funding for ovarian cancer research The Ovarian Cancer Research Program (OCRP) housed within the Department of Defense is the federal government’s only program dedicated … Continued
We’re full on into fall, and giving thanks for all that we’ve accomplished together, in a year that’s been more than a little challenging. RESEARCH ADVOCACY PATIENT SUPPORT & PROGRAMS EVENTS WAYS … Continued
I never say, ‘I have cancer,’ because it’s not mine. I’m dealing with it. Elle Simone In the same way that a complex dish is made up of distinct ingredients … Continued
Be a voice for the ovarian cancer community. Please note: The deadline for application was December 7, 2020. Sign up for email alerts to stay updated on opportunities to take … Continued
The Supreme Court is poised to consider California v. Texas, which will decide the fate of the Affordable Care Act (ACA) — their decision could threaten health coverage for millions … Continued
In August, OCRA hosted a listening session with the U.S. Food and Drug Administration (FDA) to better understand the impact of Covid-19 on clinical trial participation. Watch the full FDA … Continued
Get email updates about research news, action alerts, and ways to join the fight.
